Arca
Skip to content

Angelman syndrome (as)

Drug research and approvals for angelman syndrome (as): what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 2 studies of angelman syndrome (as) are recruiting on ClinicalTrials.gov, Health Canada has authorized 8 drug trials for it since 2013, and FDA has 0 approved and 13 open orphan designations naming it.

  • Recruiting worldwide: 2
  • Trials authorized in Canada: 8
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 2 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
May 6, 2026Randomized, multi-center, double-blind, sham-controlled, parallel group, phase III clinical study to evaluate the efficacy and safety of intrathecally…RUGONERSEN (OHB-724)OHB PEDIATRICS LTD.Pending
Oct 29, 2025A multi-center, open-label, phase 1/2 trial of the safety and efficacy of mvx-220 gene therapy administered by intra-cisterna magna injection to participants…MVX-220MAVRIX BIO, LLCPending
Mar 19, 2025Phase 3 study of the efficacy and safety of ion582 in children and adults with angelman syndromeION582Ionis PharmaceuticalsOngoing
Nov 19, 2024A phase 3, randomized, double-blind, sham-controlled study investigating the efficacy and safety of gtx-102 in pediatric subjects with angelman syndromeGTX-102Ultragenyx Pharmaceutical Inc.Closed
May 17, 2024A long-term extension trial investigating the safety and efficacy of gtx-102 in patients with angelman syndromeGTX-102Ultragenyx Pharmaceutical Inc.Closed
Dec 2, 2021A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of intrathecally administered ion582 in patients with angelman syndromeION582Ionis PharmaceuticalsClosed
Sep 3, 2020An open-label, multicenter study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of ro7248824 in participants with angelman…RO7248824RocheClosed
Mar 3, 2020A phase 1/2 open-label, multiple-dose, dose-escalating clinical trial of the safety and tolerability of gtx-102 in pediatric patients with angelman syndrome…GTX-102Ultragenyx Pharmaceutical Inc.Closed

FDA Orphan Designations

Approved first, then open designations, newest first
Oct 16, 2025non-replicating recombinant adeno-associated virus serotype…treatment of Angelman syndromeMavriX Bio, LLCDesignated
Jul 3, 2024insulin like growth factor 2 receptor ligandtreatment of Angelman syndrome.New York UniversityDesignated
Apr 29, 202414-species commensal bacterial flora with prebiotics and…treatment of Angelman syndromeBiom Pharmaceutical CorporationDesignated
May 26, 20222'-O-(2-methoxyethyl) modified antisense oligonucleotide…Treatment of Angelman SyndromeIonis Pharmaceuticals, Inc.Designated
Feb 9, 2022CannabidiolTreatment of Angelman SyndromeBenuvia Operations LLCDesignated
Mar 22, 2021CannabidiolTreatment of Angelman syndromeBiom TherapeuticsDesignated
Nov 24, 2020UBE3A antisense oligonucleotide with locked nucleic acids…Treatment of Angelman SyndromeOHB Pediatrics Ltd.Designated
Oct 22, 2020Recombinant adeno-associated virus vector containing the…Treatment of Angelman SyndromePTC Therapeutics, Inc.Designated
Oct 9, 2019cyclo(-L-Glycyl-L-2-Allylproline)Treatment of Angelman syndromeNeuren Pharmaceuticals, Ltd.Designated
Aug 28, 2019Chimeric locked nucleic acid and…Treatment of Angelman syndromeUltragenyx Pharmaceutical Inc.Designated
Aug 7, 2018[(4-benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)met…Treatment of Angelman SyndromeSeneca Biopharma, Inc.Designated
Sep 6, 20164,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-olTreatment of Angelman syndrome.Healx LimitedDesignated
Oct 29, 2015recombinant adeno-associated virus serotype 9 vector…Treatment of Angelman Syndrome.PTC Therapeutics, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.